Brief: Lucira And Loch Lomond Villa Announce Clinical Study To Tackle Tripledemic With First And Only Combination Covid-19 And Flu OTC Molecular Self-Test
06/12/2022 12:52
Dec 6 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA AND LOCH LOMOND VILLA ANNOUNCE CLINICAL STUDY TO
TACKLE
TRIPLEDEMIC WITH FIRST AND ONLY COMBINATION COVID-19 AND FLU OTC
MOLECULAR SELF-TEST
Source text for Eikon: ID:nGNX4VmW9h
Further company coverage: LHDX.O
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process